Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Adherence Between Immediate and Extended Release Adderall in Adults with ADHD
NCT00468143Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Aug 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dextroamphetamine + amphetamine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by NYU Langone Health. Primary endpoints: Medication Event Monitoring System Dosage Adherence at 8 weeks, Medication Event Monitoring System Regimen Adherence at 8 weeks and 1 more. Started Aug 2007; status: completed.
02
Drugs
dextroamphetamine + amphetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00468143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468143.